PM
CVS icon

Penbrook Management’s CVS Health CVS Stock Holding History

Penbrook Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-8,775
Closed -$600K – 109
2025
Q2 		$600K Buy
8,775
+4,275
+95% +$280K 0.23% 77
2025
Q1 		$305K Sell
4,500
-300
-6% -$18K 0.23% 83
2024
Q4 		$215K Hold
4,800
– – 0.15% 96
2024
Q3 		$302K Sell
4,800
-2,800
-37% -$163K 0.2% 85
2024
Q2 		$449K Sell
7,600
-400
-5% -$25K 0.27% 68
2024
Q1 		$638K Sell
8,000
-700
-8% -$53.5K 0.4% 55
2023
Q4 		$687K Buy
8,700
+50
+0.6% +$3.56K 0.46% 47
2023
Q3 		$604K Sell
8,650
-3,343
-28% -$237K 0.44% 48
2023
Q2 		$829K Sell
11,993
-348
-3% -$24.8K 0.6% 42
2023
Q1 		$917K Hold
12,341
– – 0.7% 37
2022
Q4 		$1.15M Buy
12,341
+350
+3% +$33.8K 0.98% 24
2022
Q3 		$1.14M Sell
11,991
-399
-3% -$39.5K 0.98% 25
2022
Q2 		$1.15M Hold
12,390
– – 0.91% 27
2022
Q1 		$1.25M Sell
12,390
-50
-0.4% -$5.25K 0.81% 36
2021
Q4 		$1.28M Sell
12,440
-200
-2% -$18.5K 0.77% 39
2021
Q3 		$1.07M Sell
12,640
-230
-2% -$19.3K 0.67% 48
2021
Q2 		$1.07M Hold
12,870
– – 0.64% 50
2021
Q1 		$968K Hold
12,870
– – 0.7% 48
2020
Q4 		$879K Hold
12,870
– – 0.68% 49
2020
Q3 		$752K Buy
12,870
+1,190
+10% +$74K 0.65% 48
2020
Q2 		$759K Buy
11,680
+380
+3% +$23.9K 0.75% 40
2020
Q1 		$670K Sell
11,300
-200
-2% -$13.4K 0.86% 36
2019
Q4 		$854K Hold
11,500
– – 0.83% 41
2019
Q3 		$725K Buy
11,500
+1,800
+19% +$107K 0.79% 47
2019
Q2 		$529K Buy
+9,700
New +$522K 0.57% 62

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Penbrook Management's CVS Position: Q3 2025 in Review

Penbrook Management sold out of CVS Health (CVS) in Q3 2025, closing a stake of 8,775 shares — an estimated $600K sold.

Penbrook Management first reported a position in CVS in Q2 2019 and held it in 25 quarters. The position peaked at $1.28M in Q4 2021. 1,835 funds tracked by Wall St. Rank hold CVS as of Q3 2025.

  • Penbrook Management reported no remaining CVS Health position as of Q3 2025 after selling out during the quarter.
  • Penbrook Management sold 8,775 CVS Health shares in Q3 2025, an estimated $600K.
  • Penbrook Management first reported a position in CVS Health in Q2 2019 and held it in 25 quarters.
  • Penbrook Management's CVS Health position peaked at $1.28M in Q4 2021.
  • 1,835 funds tracked by Wall St. Rank held CVS Health as of Q3 2025.

Based on Penbrook Management's 13F filing for Q3 2025, filed 22 Oct 2025.